Bioavailability and Bioequivalence

Bioavailability is the measuring of the extent of a therapeutically active medicine that reaches the systemic circulation and is consequently available at the site of action. Bioequivalence is the feature where if two drugs have identical active ingredients contains similar bioavailability and produce the same effect at the place of action.

The measurement of both bioavailability and bioequivalence is crucial to ensure constancy in standards of quality, efficacy &safety of Pharmaceutical dosage forms.

  • BA/BE Studies
  • Bioequivalence Cardiovascular Products
  • Bioequivalence Study Design
  • Bioequivalence Study Protocols
  • In vitro Bioequivalence
  • universal bioavailability
  • Bioavailability Metrics
  • Waiver of invivo bioavailability

Related Conference of Bioavailability and Bioequivalence

June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Baltimore, Maryland, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
August 15-17, 2018

8th World Congress Spectroscopy and Analytical Techniques

Stockholm, Sweden
September 18-19, 2018

6th European Biopharma Congress

Amsterdam, Netherlands

Bioavailability and Bioequivalence Conference Speakers

Recommended Sessions

Related Journals

Are you interested in